Alphatec Holdings, Inc. (NASDAQ:ATEC) Given Consensus Rating of “Moderate Buy” by Analysts

Alphatec Holdings, Inc. (NASDAQ:ATECGet Free Report) has been given a consensus recommendation of “Moderate Buy” by the twelve ratings firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $18.5833.

A number of research firms have recently commented on ATEC. Lake Street Capital reaffirmed a “buy” rating and set a $15.00 target price on shares of Alphatec in a research note on Wednesday, May 6th. Piper Sandler reaffirmed an “overweight” rating and set a $14.00 target price (down from $25.00) on shares of Alphatec in a research note on Wednesday, May 6th. Weiss Ratings raised Alphatec from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 6th. TD Cowen dropped their price objective on Alphatec from $20.00 to $11.00 and set a “buy” rating on the stock in a research note on Wednesday, May 6th. Finally, Wells Fargo & Company dropped their price objective on Alphatec from $28.00 to $14.00 and set an “overweight” rating on the stock in a research note on Thursday, May 7th.

Get Our Latest Research Report on Alphatec

Alphatec Trading Up 1.8%

ATEC opened at $8.28 on Friday. The stock has a market cap of $1.27 billion, a price-to-earnings ratio of -10.10 and a beta of 0.88. The stock’s 50 day moving average price is $9.12 and its 200-day moving average price is $13.94. Alphatec has a one year low of $6.82 and a one year high of $23.29. The company has a debt-to-equity ratio of 40.35, a quick ratio of 1.12 and a current ratio of 1.90.

Insider Transactions at Alphatec

In related news, Director Karen K. Mcginnis sold 6,050 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $8.01, for a total value of $48,460.50. Following the transaction, the director owned 94,671 shares of the company’s stock, valued at $758,314.71. This represents a 6.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 13.48% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Summit Securities Group LLC bought a new position in Alphatec in the first quarter worth approximately $29,000. Aster Capital Management DIFC Ltd bought a new position in Alphatec in the third quarter worth approximately $34,000. Osterweis Capital Management Inc. bought a new position in Alphatec in the second quarter worth approximately $37,000. Northwestern Mutual Wealth Management Co. grew its stake in Alphatec by 157.1% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,571 shares of the medical technology company’s stock worth $54,000 after purchasing an additional 1,571 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. bought a new position in Alphatec in the third quarter worth approximately $73,000. Institutional investors own 66.35% of the company’s stock.

Alphatec Company Profile

(Get Free Report)

Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.

Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.

Featured Stories

Analyst Recommendations for Alphatec (NASDAQ:ATEC)

Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.